back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-25 10:56 Tx date 2025-06-24 |
$PRN
Profound Medical Corp. |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+12,097 vol |
32,097 | |
| Filed 2025-05-20 08:16 Tx date 2025-05-19 |
$PRN
Profound Medical Corp. |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,671
+7,440 vol $4.93 each |
42,300 | |
| Filed 2025-05-16 17:27 Tx date 2025-05-16 |
$PRN
Profound Medical Corp. |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,843
+9,200 vol $4.77 each |
34,860 | |
| Filed 2025-05-16 09:54 Tx date 2025-05-15 |
$PRN
Profound Medical Corp. |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,023
+8,360 vol $4.43 each |
25,660 | |
| Filed 2024-11-28 12:01 Tx date 2024-11-18 |
$PRN
Profound Medical Corp. |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+5,000 vol |
20,000 | |
| Filed 2024-11-28 12:01 Tx date 2023-09-08 |
$PRN
Profound Medical Corp. |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+5,000 vol |
15,000 | |
| Filed 2024-11-28 12:00 Tx date 2022-08-15 |
$PRN
Profound Medical Corp. |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+10,000 vol |
10,000 | |
| Filed 2024-11-28 11:59 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-02 14:14 Tx date 2022-06-01 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,785
+3,000 vol $8.93 each |
16,762 | |
| Filed 2022-06-02 14:13 Tx date 2022-06-01 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,610
+500 vol $9.22 each |
13,762 | |
| Filed 2022-06-02 14:13 Tx date 2022-05-31 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$61,426
+6,762 vol $9.08 each |
13,262 | |
| Filed 2022-06-02 13:06 Tx date 2022-06-02 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,101
+538 vol $9.48 each |
7,038 | |
| Filed 2021-08-17 09:01 Tx date 2021-08-17 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,425
+6,500 vol $15.45 each |
6,500 | |
| Filed 2021-08-17 08:59 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-26 09:42 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$220,799
+10,000 vol $22.08 each |
33,300 | |
| Filed 2020-05-20 13:35 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,400
+10,000 vol $17.44 each |
23,300 | |
| Filed 2020-01-09 15:44 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-29,700 vol |
3,300 | |
| Filed 2019-11-20 10:59 Tx date 2019-11-18 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,300
+10,000 vol $11.23 each |
43,000 | |
| Filed 2018-06-19 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,660
+33,000 vol $1.02 each |
33,000 | |
| Filed 2018-06-19 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|